Regentis Biomaterials Garners Surgeon Interest for GelrinC at ICRS Summit
October 12, 2026 — Regentis Biomaterials gains surgeon interest for GelrinC, a cell-free hydrogel implant for knee cartilage regeneration, at ICRS Summit. Phase II data show 100% KOOS improvement.